Proteus syndrome is a rare, multi-system, genetic syndrome characterised by atypical and excessive growth of skeletal tissue. Clinical presentations include abnormal musculoskeletal growth and cutaneous lesions. Due to its rarity, there have been a limited number of published case reports of Proteus syndrome. This is the first case report on the management of Proteus syndrome in pregnancy. We present the case of a pregnant woman with Proteus syndrome in her first pregnancy in a large teaching hospital and discuss the considerations and challenges faced in her antenatal, intrapartum and postnatal care.
DeloneDRBrownWDGentryLR.Proteus syndrome: craniofacial and cerebral MRI. Neuroradiology1999;
41: 840–843.
3.
JohnstonJJFinnEM, Peters Ket al.
A mosaic activating mutation in. Genome Res2011; 611–619.
4.
HappleR.Lethal genes surviving by mosaicism: a possible explanation for sporadic birth defects involving the skin. J Am Acad Dermatol1987;
16: 899–906.
5.
López-CortésALeonePEFreire-PaspuelB, et al.
Mutational analysis of oncogenic AKT1 gene associated with breast cancer risk in the high altitude Ecuadorian Mestizo population. Biomed Res Int2018.
6.
ChaiHLuoAZWeerasingheP, et al.
Sorafenib downregulates ERK/Akt and STAT3 survival pathways and induces apoptosis in a human neuroblastoma cell line. Int J Clin Exp Pathol2010;
3: 408–415.
7.
BieseckerL.The challenges of Proteus syndrome: diagnosis and management. Eur J Hum Genet2006;
14: 1151–1157.
8.
TurnerJTCohenMMBieseckerLG.Reassessment of the Proteus syndrome literature: application of diagnostic criteria to published cases. Am J Med Genet2004;
130 A: 111–122.
9.
XiaoLPengBQuH, et al. Successful management of Klippel – Trenaunay syndrome in a pregnant Asian woman. 1–5.
10.
BanzicIBrankovicMMaksimovićŽ, et al.
Parkes Weber syndrome – diagnostic and management paradigms: a systematic review. Phlebology2017;
32: 371–383.
11.
Keppler-NoreuilKMLozierJOdenN, et al.
Thrombosis risk factors in PIK3CA-related overgrowth spectrum and Proteus syndrome. Am J Med Genet C Semin Med Genet2019;
181: 571–581.
12.
CohenMM.Proteus syndrome: an update. Am J Med Genet – Genet2005;
137 C: 38–52.
13.
SlavotinekAMVachaSJPetersKF, et al.
Sudden death caused by pulmonary thromboembolism in Proteus syndrome. Clin Genet2000;
58: 386–389.
14.
GundoganTGJacquemynY.Klippel-Trenaunay syndrome and pregnancy. Int Angiol2003;
22: 194–198.
15.
TihanTOkunJ.Pathology of lipomatous lesions in Proteus syndrome. Pediatr Dev Pathol1998;
1: 443–448.
HongJMLeeHJKimES, et al.
Bronchoscopic concerns in Proteus syndrome: a case report. Korean J Anesthesiol2016;
69: 523–526.
18.
CeyhanAGülhanYÇakanT, et al.
Anaesthesia for Proteus syndrome. Eur J Anaesthesiol2000;
17: 645–647.
19.
LindhurstJBieseckerLG. A characteristic pattern of cranial hyperostosis. 2017; 170: 2605–2610.
20.
Boyle-WalshEShenkinAWhiteMC, et al.
Effect of glycoprotein and protein hormones on human meningioma cell proliferation in vitro. J Endocrinol1995;
145: 155–161.
21.
HortobágyiTBenczeJMurnyákB, et al.
Pathophysiology of meningioma growth in pregnancy. Open Med (Wars)2017;
12: 195–200.
22.
KanaanIJalluAKanaanH.Management strategy for meningioma in pregnancy: a clinical study. Skull Base2003;
13: 197–202.
23.
ClarkADiGiovanniNHartS, et al.
Epidural anesthesia for cesarean delivery in a morbidly obese parturient with spinal meningioma. Ochsner J2012;
12: 145–148.
24.
PikisSCohenJERosenthalG, et al.
Spinal meningioma becoming symptomatic in the third trimester of pregnancy. J Clin Neurosci2013;
20: 1797–1799.
